METHOD FOR ANALYZING A TUMOR-SPECIFIC MARKER

BIOMARKER FOR PROSTATE CANCER

DEVICE AND METHOD FOR LOCALISING OR IDENTIFYING MALIGNANCIES

METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC PROSTATITIS AND/OR CHRONIC PELVIC PAIN SYNDROME

PSMA-TARGETING COMPOUNDS AND USES THEREOF

PSMA-targeting compounds and uses thereof

PSMA targeted fluorescent agents for image guided surgery

PSMA targeted fluorescent agents for image guided surgery

Diagnostic apparatus

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample

DIAGNOSTIC METHOD

METHOD FOR DISCRIMINATING BETWEEN PROSTATE CANCER AND A BENIGN PROSTATE DISEASE

Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling

Predicting prostate cancer recurrence using a prognostic model that combines immunohistochemical staining and gene expression profiling

Urinary polyamines as prostate cancer detection biomarkers

BIOMARKER COMBINATIONS FOR PROSTATE DISEASE

System and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer

Application of TRPM8 protein, related peptide fragment and their antibodies

Markers of the male urogenital tract

Method of diagnosing prostate cancer by detecting chemical elements

Method for discriminating between prostate cancer and a benign prostate disease

Methods for discriminating between prostate cancer and a benign prostate-disease

MULTIMODAL MICROSCOPY FOR AUTOMATED HISTOLOGIC ANALYSIS OF PROSTATE CANCER

PROSTATITIS-ASSOCIATED ANTIGENS AND METHODS OF USE THEREOF

Means and Methods for Diagnosing Recurrence of Prostate Cancer After Prostatectomy

System and method for detecting of alpha-methylacyl-CoA racemase (AMACR) and prostate cancer

MARKERS OF THE MALE UROGENITAL TRACT

Treatment of chronic pelvic pain syndrome

Cell division marker

DIAGNOSTIC APPARATUS

Methods for evaluating and implementing prostate disease treatments

Prostatitis-associated antigens and methods of use thereof

METHODS AND SYSTEMS TO DIAGNOSE A CONDITION IN AN INDIVIDUAL

ANALYSIS METHOD FOR THE IN VITRO DIAGNOSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN DOGS BY ASSAYING CANINE PROSTATE SPECIFIC ESTERASE, AND BPH TREATMENT FOLLOW UP

Method for analyzing PSA and method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA

Treatment of chronic pelvic pain syndrome

MARKER SEQUENCES FOR INFLAMMATORY PROSTATE DISEASES, PROSTATE CARCINOMA AND THEIR USE

Method of evaluating prostatic disease

Cell division marker

Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other Pathophysiologies

METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION

PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF

DIAGNOSTIC SUBSTANCE AND METHOD FOR THE DIAGNOSIS OF PROSTATE DISEASES

METHODS AND SYSTEMS FOR PROSTATE HEALTH MONITORING

METHODS FOR DIAGNOSIS OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME

Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)

Method for discriminating between prostatic cancer and benign prostatic hyperplasia

Methods for Prognosis and Diagnosis of Chronic Prostatitis/Pelvic Pain Syndrome and Interstitial Cystitis

ANIMAL MODEL FOR PROSTATIC STROMAL HYPERPLASIA

Methods for evaluating and implementing prostate disease treatments

Glycomic patterns for the detection of disease

BIOMARKERS FOR SCREENING, PREDICTING, AND MONITORING BENIGN PROSTATE HYPERPLASIA

Cell division marker

Prostate-specific membrane antigen

METHOD TO PREDICT RISK OF BPH PROGRESSION

Tissue-and serum-derived glycoproteins and methods of their use

Use of prostate specific antigen to predict drug response

Genetic markers associated with benign prostatic hyperplasia

Prostate-specific membrane antigen

JM-27 as a marker of benign prostatic hyperplasia

Method for screening agents against human prostate disease

Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs

Prevention and treatment of benign prostatic hyperplasia

Dosage forms for treatment of benign prostatic hyperplasia

Full-length prostate selective polynucleotides and polypeptides

Methods for diagnosing urinary tract and prostatic disorders

Protein markers for human benign prostatic hyperplasia (BPH)